RODEXKE. Infiltración con ropivacaína, dexmedetomidina y ketorolac en cirugía espinal: Una estrategia para disminuir el consumo de opioides

2do Premio Beca Asociación Argentina de Neurocirugía. XV Jornadas de Neurocirugía 2019

Abstract

Objectives: To assess the effectiveness of a surgical site infiltration with ropivacaine, dexmedetomidine and ketorolac, in reducing opioid consumption in patients with a transpedicular dorsolumbar instrumentation using a minimally invasive technique.
Materials y methods: We retrospectively collected data from patient’s charts from June of 2016 to December of 2018. 32 patients with minimally invasive transpedicular dorsolumbar instrumentation, who met all criteria, were included in the analysis. During wound closure a mixture of 150mg of ropivacaine, 0,7mcg/kg of dexmedetomidine and 60mg of ketorolac, diluted in normal saline to achieve 40ml was injected (Group M). We compared them with patients in whom only 150mg of ropivacaine and saline where injected in the surgical site (Group E).
Results: Morphine equivalents use during the first 72 hours postoperative had a median of 0mg for group M, and of 9,5mg (IQR of 13.35), with a p<0,000. On the contrary, morphine use during post anesthesia care unit stance had a median of 0mg (IQR of 2) for group M and of 2mg (IQR of 5) for group E, without a statistically significant difference, p=0,132.
Conclusion: The result of the analysis of opioid consumption during the first 72 hours postoperative allows concluding that the infiltration of these 3 drugs together its superior to the standard infiltration with ropivacaine, independently of the analgesic strategy used during the surgery.